May 22, 2026 Genome-wide association and population-tailored polygenic risk for Parkinson’s disease in Taiwan
May 16, 2026 Favipiravir vs Ribavirin for Lassa Fever: Phase 2 Trial Highlights Safety and Treatment Potential in Nigeria
